1173 related articles for article (PubMed ID: 29432754)
21. Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms.
Torre A; Paillusson B; Fain V; Labauge P; Pelage JP; Fauconnier A
Hum Reprod; 2014 Mar; 29(3):490-501. PubMed ID: 24430777
[TBL] [Abstract][Full Text] [Related]
22. Uterine artery embolization as a treatment option for uterine myomas.
Marshburn PB; Matthews ML; Hurst BS
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
[TBL] [Abstract][Full Text] [Related]
23. A single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35-49 years.
Baird DD; Saldana TM; Shore DL; Hill MC; Schectman JM
Hum Reprod; 2015 Dec; 30(12):2936-44. PubMed ID: 26409013
[TBL] [Abstract][Full Text] [Related]
24. Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial.
AbdElmagied AM; Vaughan LE; Weaver AL; Laughlin-Tommaso SK; Hesley GK; Woodrum DA; Jacoby VL; Kohi MP; Price TM; Nieves A; Miller MJ; Borah BJ; Gorny KR; Leppert PC; Lemens MA; Stewart EA
Am J Obstet Gynecol; 2016 Sep; 215(3):338.e1-338.e18. PubMed ID: 27073063
[TBL] [Abstract][Full Text] [Related]
25. Ulipristal acetate for uterine fibroids: 2 years of real world experience in a UK hospital.
Woodhead N; Pounds R; Irani S; Pradhan P
J Obstet Gynaecol; 2018 Aug; 38(6):813-817. PubMed ID: 29526144
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of the psychosocial impact of fibroids before and after treatment.
Go VAA; Thomas MC; Singh B; Prenatt S; Sims H; Blanck JF; Segars JH
Am J Obstet Gynecol; 2020 Nov; 223(5):674-708.e8. PubMed ID: 32474012
[TBL] [Abstract][Full Text] [Related]
27. Use of medical, surgical and complementary treatments among women with fibroids.
Jacoby VL; Jacoby A; Learman LA; Schembri M; Gregorich SE; Jackson R; Kuppermann M
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():220-5. PubMed ID: 25445104
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiological data for uterine fibroids in France in 2010-2012 in medical center--analysis from the French DRG-based information system (PMSI)].
Fernandez H; Chabbert-Buffet N; Koskas M; Nazac A
J Gynecol Obstet Biol Reprod (Paris); 2014 Oct; 43(8):616-28. PubMed ID: 25017711
[TBL] [Abstract][Full Text] [Related]
29. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial.
de Bruijn AM; Ankum WM; Reekers JA; Birnie E; van der Kooij SM; Volkers NA; Hehenkamp WJ
Am J Obstet Gynecol; 2016 Dec; 215(6):745.e1-745.e12. PubMed ID: 27393268
[TBL] [Abstract][Full Text] [Related]
30. Clinical presentation of fibroids.
Gupta S; Jose J; Manyonda I
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):615-26. PubMed ID: 18372219
[TBL] [Abstract][Full Text] [Related]
31. Understanding clinical features of adenomyosis: a case control study.
Shrestha A; Sedai LB
Nepal Med Coll J; 2012 Sep; 14(3):176-9. PubMed ID: 24047010
[TBL] [Abstract][Full Text] [Related]
32. The impact of fibroid treatments on quality of life and mental health: a systematic review.
Neumann B; Singh B; Brennan J; Blanck J; Segars JH
Fertil Steril; 2024 Mar; 121(3):400-425. PubMed ID: 38246400
[TBL] [Abstract][Full Text] [Related]
33. SOGC clinical practice guidelines. Uterine fibroid embolization (UFE). Number 150, October 2004.
Society of Obstetricians and Gynaecologists of Canada
Int J Gynaecol Obstet; 2005 Jun; 89(3):305-18. PubMed ID: 16001461
[TBL] [Abstract][Full Text] [Related]
34. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
35. Uterine fibroid embolisation: initial experience in our local population.
Jawad RA; Imaad-ur-Rehman ; Rana AI; Tariq N
J Pak Med Assoc; 2013 Dec; 63(12):1482-5. PubMed ID: 24397089
[TBL] [Abstract][Full Text] [Related]
36. EMAS position statement: management of uterine fibroids.
Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
[TBL] [Abstract][Full Text] [Related]
37. The role of uterine artery embolization in the management of uterine fibroids.
Tropeano G
Curr Opin Obstet Gynecol; 2005 Aug; 17(4):329-32. PubMed ID: 15976535
[TBL] [Abstract][Full Text] [Related]
38. Aromatase inhibitors for uterine fibroids.
Song H; Lu D; Navaratnam K; Shi G
Cochrane Database Syst Rev; 2013 Oct; (10):CD009505. PubMed ID: 24151065
[TBL] [Abstract][Full Text] [Related]
39. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis.
Pron G
Ont Health Technol Assess Ser; 2015; 15(4):1-86. PubMed ID: 26357530
[TBL] [Abstract][Full Text] [Related]
40. Fibroids and Urinary Symptoms Study (FUSS).
Bochenska K; Lewitt T; Marsh EE; Pidaparti M; Lewicky-Gaupp C; Mueller MG; Kenton K
Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):e481-e483. PubMed ID: 33105342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
